2025 Q4 -tulosraportti
14 päivää sitten
‧49 min
8,00 NOK/osake
Irtoamispäivä 7.5.
2,96%Tuotto/v
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 125 | - | - | ||
| 1 | - | - | ||
| 134 | - | - | ||
| 184 | - | - | ||
| 46 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 7.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 24.10.2025 | ||
2025 Q2 -tulosraportti 20.8.2025 | ||
2025 Q1 -tulosraportti 9.5.2025 | ||
2024 Q4 -tulosraportti 28.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
4 t sitten4 t sittenMEDI: Intertrade Shipping AS purchases Medistim shares Close i dag kl. 14:14 ∙ Oslo Børs Medistim Intertrade Shipping AS, which is partly-owned and controlled by Øyvin A. Brøymer, has today purchased 29,266 shares in Medistim ASA at NOK 200.5776 per share, - totaling NOK 5,875,974.14. Øyvin A. Brøymer is the chairman of the board in Medistim ASA. After the purchase, Intertrade Shipping AS owns 965,001 shares in the company. Fløtemarken AS, which is a 100% owned company of Intertrade Shipping AS, additionally owns 1,285,000 shares in Medistim ASA. In total, Øyvin A. Brøymer controls 2,250,001 shares in Medistim ASA after the purchase.
·6 t sittenI would like to know the reason for selling below 200 kr from some of those who are doing it now, after the company delivered stellar figures in Q4, a record year last year, and the highest dividend to date. I would appreciate hearing the reason for that, unless it's personal reasons, of course.·5 t sittenTook this in just under 200 today, have been waiting for it to come down here. Great company on all parameters.·4 t sittenIt is never easy to time 100%, at least not under today's market conditions. I'm trying to invest a bit away from cyclical stocks and have had some price alerts around interesting companies, this was one of them.- ·1 päivä sittenThis stock seems to be a somewhat forgotten stock. Very rarely mentioned in the financial press, and very little commented on in forums. This gem has been on the stock exchange for a long time, delivers good results with a record in Q4 and for the full year 2025. Quite decent dividend (8 kr /approx 4%) and an attractive portfolio of own products for hospitals and healthcare enterprises. This is not something AI can destroy, and this is also not a market that will cease to exist; on the contrary, healthcare will likely only grow due to an aging population. After the Q4 figures, it rose so much that I was tempted to sell out at 230, but have now bought back my shares again, at a price I find very favorable. No reason for Medistim to fall as it has done after the figures other than that it is an unsettled market. If one is long-term, one sits well in this fine stock, in my opinion.
·27.2.Extremely strong figures from Medistim! EPS of 2.08kr for the quarter - up from 1.91 in Q3/25 and 1,16 in Q4/24. Announces 8kr/share in dividend. - > up from 6 kr in 2024. I don't think there are many companies on Oslo Børs that are priced at a P/E of 24,5 and a div-yield of 3.7%, which at the same time can show a year/year EPS growth of 54%, top-line growth for the year of 24.4% and which has done this for almost 20 years!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
14 päivää sitten
‧49 min
8,00 NOK/osake
Irtoamispäivä 7.5.
2,96%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- 4 t sitten4 t sittenMEDI: Intertrade Shipping AS purchases Medistim shares Close i dag kl. 14:14 ∙ Oslo Børs Medistim Intertrade Shipping AS, which is partly-owned and controlled by Øyvin A. Brøymer, has today purchased 29,266 shares in Medistim ASA at NOK 200.5776 per share, - totaling NOK 5,875,974.14. Øyvin A. Brøymer is the chairman of the board in Medistim ASA. After the purchase, Intertrade Shipping AS owns 965,001 shares in the company. Fløtemarken AS, which is a 100% owned company of Intertrade Shipping AS, additionally owns 1,285,000 shares in Medistim ASA. In total, Øyvin A. Brøymer controls 2,250,001 shares in Medistim ASA after the purchase.
- ·6 t sittenI would like to know the reason for selling below 200 kr from some of those who are doing it now, after the company delivered stellar figures in Q4, a record year last year, and the highest dividend to date. I would appreciate hearing the reason for that, unless it's personal reasons, of course.·5 t sittenTook this in just under 200 today, have been waiting for it to come down here. Great company on all parameters.·4 t sittenIt is never easy to time 100%, at least not under today's market conditions. I'm trying to invest a bit away from cyclical stocks and have had some price alerts around interesting companies, this was one of them.
- ·1 päivä sittenThis stock seems to be a somewhat forgotten stock. Very rarely mentioned in the financial press, and very little commented on in forums. This gem has been on the stock exchange for a long time, delivers good results with a record in Q4 and for the full year 2025. Quite decent dividend (8 kr /approx 4%) and an attractive portfolio of own products for hospitals and healthcare enterprises. This is not something AI can destroy, and this is also not a market that will cease to exist; on the contrary, healthcare will likely only grow due to an aging population. After the Q4 figures, it rose so much that I was tempted to sell out at 230, but have now bought back my shares again, at a price I find very favorable. No reason for Medistim to fall as it has done after the figures other than that it is an unsettled market. If one is long-term, one sits well in this fine stock, in my opinion.
- ·27.2.Extremely strong figures from Medistim! EPS of 2.08kr for the quarter - up from 1.91 in Q3/25 and 1,16 in Q4/24. Announces 8kr/share in dividend. - > up from 6 kr in 2024. I don't think there are many companies on Oslo Børs that are priced at a P/E of 24,5 and a div-yield of 3.7%, which at the same time can show a year/year EPS growth of 54%, top-line growth for the year of 24.4% and which has done this for almost 20 years!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 125 | - | - | ||
| 1 | - | - | ||
| 134 | - | - | ||
| 184 | - | - | ||
| 46 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 7.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 24.10.2025 | ||
2025 Q2 -tulosraportti 20.8.2025 | ||
2025 Q1 -tulosraportti 9.5.2025 | ||
2024 Q4 -tulosraportti 28.2.2025 |
2025 Q4 -tulosraportti
14 päivää sitten
‧49 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 7.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 24.10.2025 | ||
2025 Q2 -tulosraportti 20.8.2025 | ||
2025 Q1 -tulosraportti 9.5.2025 | ||
2024 Q4 -tulosraportti 28.2.2025 |
8,00 NOK/osake
Irtoamispäivä 7.5.
2,96%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- 4 t sitten4 t sittenMEDI: Intertrade Shipping AS purchases Medistim shares Close i dag kl. 14:14 ∙ Oslo Børs Medistim Intertrade Shipping AS, which is partly-owned and controlled by Øyvin A. Brøymer, has today purchased 29,266 shares in Medistim ASA at NOK 200.5776 per share, - totaling NOK 5,875,974.14. Øyvin A. Brøymer is the chairman of the board in Medistim ASA. After the purchase, Intertrade Shipping AS owns 965,001 shares in the company. Fløtemarken AS, which is a 100% owned company of Intertrade Shipping AS, additionally owns 1,285,000 shares in Medistim ASA. In total, Øyvin A. Brøymer controls 2,250,001 shares in Medistim ASA after the purchase.
- ·6 t sittenI would like to know the reason for selling below 200 kr from some of those who are doing it now, after the company delivered stellar figures in Q4, a record year last year, and the highest dividend to date. I would appreciate hearing the reason for that, unless it's personal reasons, of course.·5 t sittenTook this in just under 200 today, have been waiting for it to come down here. Great company on all parameters.·4 t sittenIt is never easy to time 100%, at least not under today's market conditions. I'm trying to invest a bit away from cyclical stocks and have had some price alerts around interesting companies, this was one of them.
- ·1 päivä sittenThis stock seems to be a somewhat forgotten stock. Very rarely mentioned in the financial press, and very little commented on in forums. This gem has been on the stock exchange for a long time, delivers good results with a record in Q4 and for the full year 2025. Quite decent dividend (8 kr /approx 4%) and an attractive portfolio of own products for hospitals and healthcare enterprises. This is not something AI can destroy, and this is also not a market that will cease to exist; on the contrary, healthcare will likely only grow due to an aging population. After the Q4 figures, it rose so much that I was tempted to sell out at 230, but have now bought back my shares again, at a price I find very favorable. No reason for Medistim to fall as it has done after the figures other than that it is an unsettled market. If one is long-term, one sits well in this fine stock, in my opinion.
- ·27.2.Extremely strong figures from Medistim! EPS of 2.08kr for the quarter - up from 1.91 in Q3/25 and 1,16 in Q4/24. Announces 8kr/share in dividend. - > up from 6 kr in 2024. I don't think there are many companies on Oslo Børs that are priced at a P/E of 24,5 and a div-yield of 3.7%, which at the same time can show a year/year EPS growth of 54%, top-line growth for the year of 24.4% and which has done this for almost 20 years!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 125 | - | - | ||
| 1 | - | - | ||
| 134 | - | - | ||
| 184 | - | - | ||
| 46 | - | - |
Välittäjätilasto
Dataa ei löytynyt